Accuray | ARAY - Selling And Administration Expenses


Accuray reported $124.78M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Artivion USD 55.75M 4.54M Dec/2025
AtriCure USD 82.56M 1.99M Jun/2026
Boston Scientific USD 1.68B 120M Sep/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Inogen USD 43.77M 510K Jun/2024
Mesa Laboratories USD 27.31M 380K Sep/2024
Orthofix International USD 130.35M 11.31M Dec/2025
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Trinity Biotech USD 5.78M 405K Dec/2025